The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Fid?s brings core strengths across imaging applications and human biology, supporting work in digestive disease, GI oncology, and select solid tumors
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
The inspection concluded with one minor observation in Form 483
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
This collaboration turns kitting into a strategic advantage for sponsors and sites
Speakers are: Dr. Alok Khullar, Senior Technology Leader, Pidilite Industries; Dr. Kamlesh Pai Fondekar, Head - R&D, Godrej Agrovet; Dr. Hiten Mehta, Head - R&D (Chlor-Alkali), Aditya Birla Chemicals; Dr. Anil Kumar Soni, Head - Application Development, R&D, Clariant Chemicals India; Dr. Rupak Paul, Deputy General Manager – Formulation, Rallis India; Dr. Manish M. Khandagale, Senior Field Application Specialist, Revvity Signals; and Pravin Prashant, Executive Editor, Indian Pharma Post
The U.S. FDA issued a Form 483 with five observations
At the end of the current inspection, a 'Form 483' was issued with 5 observations which are procedural in nature and no data integrity issues were reported
Subscribe To Our Newsletter & Stay Updated
